Q7T3T4
Gene name |
SGMS1 (MOB, RCJMB04_29o9) |
Protein name |
Phosphatidylcholine:ceramide cholinephosphotransferase 1 |
Names |
Protein Mob, Sphingomyelin synthase 1 |
Species |
Gallus gallus (Chicken) |
KEGG Pathway |
gga:378907 |
EC number |
2.7.8.27: Transferases for other substituted phosphate groups |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q7T3T4
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q7T3T4-F1 | Predicted | AlphaFoldDB |
No variants for Q7T3T4
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q7T3T4 | |||||
No associated diseases with Q7T3T4
Functions
| Description | ||
|---|---|---|
| EC Number | 2.7.8.27 | Transferases for other substituted phosphate groups |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of endoplasmic reticulum membrane | The component of the endoplasmic reticulum membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| integral component of Golgi membrane | The component of the Golgi membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| ceramide cholinephosphotransferase activity | Catalysis of the reaction: CDP-choline + ceramide = CMP + H(+) + sphingomyelin. |
| kinase activity | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
| sphingomyelin synthase activity | Catalysis of the reaction: 1,2-diacyl-sn-glycero-3-phosphocholine + ceramide = 1,2-diacyl-sn-glycerol + sphingomyelin. |
6 GO annotations of biological process
| Name | Definition |
|---|---|
| apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| ceramide biosynthetic process | The chemical reactions and pathways resulting in the formation of ceramides, any N-acylated sphingoid. |
| inflammatory response | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| negative regulation of apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
| sphingomyelin biosynthetic process | The chemical reactions and pathways resulting in the formation of sphingomyelin, N-acyl-4-sphingenyl-1-O-phosphorylcholine. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSGRMKEVVS | WSPEEVTNWL | MENAVPEYCE | PLKSFTGQDL | INLTEEDFKK | TPLSRVSSDS |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GQQLLHMIET | LKMAHHIEAH | KNGHVNGHIH | VSVNNTAHEN | GFSSKTKLNG | VPNGYKKEMI |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KIPMPEPERL | QYPMEWGKTF | LAFIYALFCF | IFTTVTISVV | HERVPPKEVQ | PPLPDAFFDR |
| 190 | 200 | 210 | 220 | 230 | 240 |
| FDRVQWAFSI | CEINGMILVG | LWLVQWLLLK | YKSIISRRFF | CIVCTLYLYR | CITMYVTTLP |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VPGMHFKCSP | KLFGDWESHL | RRIMKLIAGG | GLSITGSHNM | CGDYLYSGHT | VILTLTYLFI |
| 310 | 320 | 330 | 340 | 350 | 360 |
| KEYSPRRLWW | YHWLCWTLSM | VGMFCILLAH | DHYTVDVVVA | YYITTRLFWW | YHTMANQQVL |
| 370 | 380 | 390 | 400 | 410 | |
| KEASQTNLLA | RVWWYKPFQY | FEKNVQGIVP | RSYHWPFPWP | VLHRGRQVKY | SRLVNDT |